Jonathan Mayito

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

PloS one

PLOS global public health

medRxiv : the preprint server for health sciences

JMIR public health and surveillance

Makerere University Walter Reed Project

Makerere University College of Health Sciences (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Makerere University Walter Reed Project Jan 20 2015

Uganda

Medical Officer Public Health Evalautions :: Research

Education History

Makerere University College of Health Sciences Aug 22 2010 - May 30 2013

Uganda

MSC :: Medicine

Publications

Christine Wiltshire Sekaggya, Irene Mbabazi, Ruth Nabisere-Arinaitwe, Grace Banturaki, Lucy Alinaitwe, Brian Otalo, Florence Aber, Juliet Nampala, Rogers Owor, Josephine Bayiga, Eva Laker Agnes Odongpiny, Barbara Castelnuovo, Jonathan Mayito, Moorine Sekadde, Jotam G Pasipanodya, Stavia Turyahabwe, Stella Zawedde-Muyanja
Clinical Predictors of 3-Months Isoniazid Rifapentine (3HP) - Related Adverse Drug Reactions (ADR) During Tuberculosis Preventive Therapy. (PAnDoRA-3HP study): An Observational Study Protocol. medRxiv : the preprint server for health sciences (2024)
Fahad Lwigale, Daniel Kibombo, Simon Dembe Kasango, Dickson Tabajjwa, Collins G K Atuheire, Joseph Kungu, John Bosco Kalule, Morgan Otita, Francis Kakooza, Immaculate Nabukenya, Jonathan Mayito, Innocent B Rwego
Prevalence, resistance profiles and factors associated with skin and soft-tissue infections at Jinja regional referral hospital: A retrospective study. PLOS global public health 4 (8) (2024)
Christine Wiltshire Sekaggya, Irene Mbabazi, Ruth Nabisere-Arinaitwe, Grace Banturaki, Lucy Alinaitwe, Brian Otalo, Florence Aber, Juliet Nampala, Rogers Owor, Josephine Bayiga, Eva Laker Agnes Odongpiny, Barbara Castelnuovo, Jonathan Mayito, Moorine Sekadde, Jotam G Pasipanodya, Stavia Turyahabwe, Stella Zawedde-Muyanja
Clinical Predictors of 3-Months Isoniazid Rifapentine (3HP) - Related Adverse Drug Reactions (ADR) During Tuberculosis Preventive Therapy. (PAnDoRA-3HP study): An Observational Study Protocol. medRxiv : the preprint server for health sciences (2024)
Fahad Lwigale, Daniel Kibombo, Simon Dembe Kasango, Dickson Tabajjwa, Collins G K Atuheire, Joseph Kungu, John Bosco Kalule, Morgan Otita, Francis Kakooza, Immaculate Nabukenya, Jonathan Mayito, Innocent B Rwego
Prevalence, resistance profiles and factors associated with skin and soft-tissue infections at Jinja regional referral hospital: A retrospective study. PLOS global public health 4 (8) (2024)
Christine Wiltshire Sekaggya, Irene Mbabazi, Ruth Nabisere-Arinaitwe, Grace Banturaki, Lucy Alinaitwe, Brian Otalo, Florence Aber, Juliet Nampala, Rogers Owor, Josephine Bayiga, Eva Laker Agnes Odongpiny, Barbara Castelnuovo, Jonathan Mayito, Moorine Sekadde, Jotam G Pasipanodya, Stavia Turyahabwe, Stella Zawedde-Muyanja
Clinical Predictors of 3-Months Isoniazid Rifapentine (3HP) - Related Adverse Drug Reactions (ADR) During Tuberculosis Preventive Therapy. (PAnDoRA-3HP study): An Observational Study Protocol. medRxiv : the preprint server for health sciences (2024)
Jonathan Mayito, Adrian R Martineau, Divya Tiwari, Lydia Nakiyingi, David P Kateete, Stephen T Reece, Irene Andia Biraro
Determinants of QuantiFERON Plus-diagnosed tuberculosis infection in adult Ugandan TB contacts: A cross-sectional study. PloS one 18 (3) (2023)
Jonathan Mayito, Adrian R Martineau, Divya Tiwari, Lydia Nakiyingi, David P Kateete, Stephen T Reece, Irene Andia Biraro
Determinants of QuantiFERON Plus-diagnosed tuberculosis infection in adult Ugandan TB contacts: A cross-sectional study. PloS one 18 (3) (2023)
Jonathan Mayito, David B Meya, Akia Miriam, Flavia Dhikusooka, Joshua Rhein, Christine Sekaggya-Wiltshire
Monocyte to Lymphocyte ratio is highly specific in diagnosing latent tuberculosis and declines significantly following tuberculosis preventive therapy: A cross-sectional and nested prospective observational study. PloS one 18 (11) (2023)
Jonathan Mayito, Adrian R Martineau, Divya Tiwari, Lydia Nakiyingi, David P Kateete, Stephen T Reece, Irene Andia Biraro
Determinants of QuantiFERON Plus-diagnosed tuberculosis infection in adult Ugandan TB contacts: A cross-sectional study. PloS one 18 (3) (2023)
Simon Muchuro, Rita Makabayi-Mugabe, Joseph Musaazi, Jonathan Mayito, Stella Zawedde-Muyanja, Mabel Nakawooya, Didas Tugumisirize, Patrick Semanda, Steve Wandiga, Susan Nabada-Ndidde, Abel Nkolo, Stavia Turyahabwe
Integrating interferon-gamma release assay testing into provision of tuberculosis preventive therapy is feasible in a tuberculosis high burden resource-limited setting: A mixed methods study. PLOS global public health 2 (7) (2022)
Susan Nabadda, Francis Kakooza, Reuben Kiggundu, Richard Walwema, Joel Baziira, Jonathan Mayito, Ibrahimm Mugerwa, Musa Sekamatte, Andrew Kambugu, Mohammed Lamorde, Henry Kajumbula, Henry Mwebasa
Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data. JMIR public health and surveillance 7 (10) (2021)
Jonathan Mayito, Irene Andia-Biraro, Stephen T Reece, Adrian R Martineau, David Patrick Kateete
Detection of Mycobacterium tuberculosis DNA in CD34 + peripheral blood mononuclear cells of Ugandan adults with latent infection: a cross-sectional and nested prospective study. AAS open research 3 (2020)
Jonathan Mayito, David B Meya, Joshua Rhein, Christine Sekaggya-Wiltshire
Utility of the monocyte to lymphocyte ratio in diagnosing latent tuberculosis among HIV-infected individuals with a negative tuberculosis symptom screen. PloS one 15 (11) (2020)

Jonathan Mayito.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jonathan Mayito